Showing results (1311-1320 of 1,823) with videos related to
Sort By:
Pageof 183
Journal of Interventional Cardiology|October 23, 2023
Temporal Trends and Early Outcomes of Transcatheter versus Surgical Mitral Valve Repair in Atrial Fibrillation PatientsChi Zhou, Kai Tan, Weili Liu, et al.Journal of Interventional Cardiology|July 10, 2023
Resting Full-Cycle Ratio versus Fractional Flow Reserve: A SWEDEHEART-Registry-Based Comparison of Two Physiological Indexes for Assessing Coronary Stenosis SeverityStephen Malmberg, Jörg Lauermann, Patric Karlström, et al.Journal of Interventional Cardiology|July 14, 2010
Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm scheduled for transcatheter closure may play a role in aura genesisGianluca Rigatelli, Fabio Dell'avvocata, Paolo Cardaioli, et al.Journal of Interventional Cardiology|November 20, 2020
Incidence and Predictors of Structural Valve Deterioration after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-AnalysisYu-Xiang Long, Zeng-Zhang LiuJournal of Interventional Cardiology|April 24, 2004
Transcatheter atrial septal defect closure assisted by intracardiac echocardiography: 3-year follow-upMario Zanchetta, Gianluca Rigatelli, Luigi Pedon, et al.Journal of Interventional Cardiology|May 27, 2006
Impact of age on the outcomes of women following percutaneous coronary intervention in the bare-metal stent eraSudhir Rathore, Julie Rhys, Maurice B Buchalter, et al.Journal of Interventional Cardiology|April 21, 2021
Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical OutcomesIan B A Menown, Mamas A Mamas, James M Cotton, et al.Journal of Interventional Cardiology|December 12, 2012
Angiographic and clinical outcomes of everolimus-eluting stent in the treatment of extra long stenoses (AEETES)Man-Hong Jim, Kai-Hang Yiu, Hee-Hwa Ho, et al.Journal of Interventional Cardiology|June 2, 2016
Comparison of 4.5-Year Outcomes of Bare-Metal and Zotarolimus-Eluting Stents in New YorkFeng Qian, Ye Zhong, Pornchanok Kheocha-On, et al.Journal of Interventional Cardiology|February 18, 2015
The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarctionFrederic Casassus, Jerome Corre, Lionel Leroux, et al.Pageof 183